electroCore, Inc. (NASDAQ:ECOR – Get Free Report) insider Michael Fox purchased 2,500 shares of electroCore stock in a transaction dated Tuesday, November 17th. The stock was bought at an average cost of $5.25 per share, with a total value of $13,125.00. Following the completion of the purchase, the insider owned 132,500 shares in the company, valued at approximately $695,625. This trade represents a 1.92% increase in their position. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website.
electroCore Price Performance
Shares of ECOR opened at $5.17 on Thursday. electroCore, Inc. has a one year low of $4.37 and a one year high of $12.70. The company has a market capitalization of $47.72 million, a PE ratio of -3.72 and a beta of 1.23. The company’s fifty day moving average price is $8.75 and its 200 day moving average price is $7.71.
electroCore (NASDAQ:ECOR – Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.14. The business had revenue of $9.69 million for the quarter, compared to the consensus estimate of $10.93 million. Analysts anticipate that electroCore, Inc. will post -1.17 earnings per share for the current year.
Hedge Funds Weigh In On electroCore
An institutional investor recently bought a new stake in electroCore stock. Cetera Investment Advisers acquired a new stake in shares of electroCore, Inc. (NASDAQ:ECOR – Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 32,950 shares of the company’s stock, valued at approximately $357,000. Cetera Investment Advisers owned approximately 0.36% of electroCore as of its most recent SEC filing. 26.74% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of electroCore in a research report on Monday, September 21st. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, electroCore currently has a consensus rating of “Hold” and a consensus target price of $18.00.
View Our Latest Stock Report on electroCore
About electroCore
electroCore is a medical technology company that develops non-invasive bioelectronic therapies. Its products use non-invasive vagus nerve stimulation (nVNS), which delivers gentle electrical stimulation through the skin to activate the vagus nerve. The company’s gammaCore device is used for the treatment of certain headache conditions, including migraine and cluster headache, subject to its regulatory clearances and indications. electroCore also offers Truvaga, a consumer wellness product that uses non-invasive vagus nerve stimulation.
Featured Stories
- Five stocks we like better than electroCore
- From Berlin to Brussels: Tesla’s $3.3 Billion Robotaxi Gamble
- Target Stock Is Up Over 70%—Has the Easy Money Already Been Made?
- Amazon’s Zoox Just Joined Uber—Could That Change the Robotaxi Threat?
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.
